We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVTA
1751
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.76M | ﹤0.01% |
165,872
+1,974
| +1% | +$33.1K |
|
1752
Coherus Oncology
CHRS
$196M
| $2.75M | ﹤0.01% |
188,167
+10,653
| +6% | +$181K |
|
1753
Interface
TILE
$2.22B
| $2.75M | ﹤0.01% |
219,921
+2,765
| +1% | +$32.9K |
|
1754
AdvanSix
ASIX
$444M
| $2.74M | ﹤0.01% |
102,192
+921
| +0.9% | +$23.5K |
|
1755
MGP Ingredients
MGPI
$375M
| $2.73M | ﹤0.01% |
46,244
-2,627
| -5% | -$159K |
|
1756
Otter Tail
OTTR
$3.94B
| $2.73M | ﹤0.01% |
59,237
-4,202
| -7% | -$180K |
|
1757
Agilysys
AGYS
$3.06B
| $2.72M | ﹤0.01% |
56,776
+1,399
| +3% | +$69.6K |
|
1758
Penske Automotive Group
PAG
$14.2B
| $2.72M | ﹤0.01% |
33,852
-45,181
| -57% | -$3.16M |
|
1759
AppFolio
APPF
$7.04B
| $2.71M | ﹤0.01% |
19,176
-1,605
| -8% | -$249K |
|
1760
BioCryst Pharmaceuticals
BCRX
$2.4B
| $2.71M | ﹤0.01% |
266,467
-32,020
| -11% | -$330K |
|
|
BAND
1761
Bandwidth Inc
BAND
$1.61B
| $2.71M | ﹤0.01% |
21,349
-1,702
| -7% | -$264K |
|
1762
Arbor Realty Trust
ABR
$998M
| $2.7M | ﹤0.01% |
169,808
-9,434
| -5% | -$146K |
|
|
CKH
1763
DELISTED
Seacor Holdings Inc.
CKH
| $2.69M | ﹤0.01% |
66,140
-49
| -0.1% | -$2.05K |
|
1764
Champion Homes
SKY
$5.14B
| $2.69M | ﹤0.01% |
59,464
-4,921
| -8% | -$198K |
|
|
PS
1765
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $2.69M | ﹤0.01% |
120,474
+24,394
| +25% | +$523K |
|
1766
Central Pacific Financial
CPF
$1B
| $2.67M | ﹤0.01% |
100,085
+656
| +0.7% | +$15K |
|
|
AVYA
1767
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.67M | ﹤0.01% |
95,144
-9,644
| -9% | -$258K |
|
1768
WisdomTree
WT
$3.22B
| $2.66M | ﹤0.01% |
425,718
-259
| -0.1% | -$1.48K |
|
1769
Scansource
SCSC
$1.12B
| $2.65M | ﹤0.01% |
88,648
+1,320
| +2% | +$38.2K |
|
1770
Artivion
AORT
$1.32B
| $2.65M | ﹤0.01% |
117,454
+2,236
| +2% | +$54.7K |
|
1771
Helix Energy Solutions
HLX
$1.41B
| $2.65M | ﹤0.01% |
524,151
+8,152
| +2% | +$40.6K |
|
|
MAGN
1772
Magnera Corp
MAGN
$460M
| $2.65M | ﹤0.01% |
11,871
+16
| +0.1% | +$3.56K |
|
|
TWOU
1773
DELISTED
2U Inc
TWOU
| $2.64M | ﹤0.01% |
2,298
-61
| -3% | -$77.3K |
|
|
MNTV
1774
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $2.63M | ﹤0.01% |
143,814
-11,110
| -7% | -$250K |
|
1775
United Fire Group
UFCS
$1.4B
| $2.63M | ﹤0.01% |
75,478
+1,730
| +2% | +$54.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.